Abstract
Antiseizure medications (ASMs) are the second most widely prescribed psychotropic for people with intellectual disabilities in England. Multiple psychotropic prescribing is prevalent in almost half of people with intellectual disabilities on ASMs. This analysis identifies limited evidence of ASM benefit in challenging behaviour management and suggests improvements needed to inform clinical practice.
Original language | English |
---|---|
Pages (from-to) | 191-195 |
Number of pages | 5 |
Journal | British Journal of Psychiatry |
Volume | 222 |
Issue number | 5 |
DOIs | |
Publication status | Published - 14 Feb 2023 |
ASJC Scopus subject areas
- Psychiatry and Mental Health
Keywords
- challenging behaviour
- Epilepsy
- learning disabilities
- neurodevelopmental
- psychiatric conditions